The annual number of PVAD-supported PCIs more than quadrupled between 2013 and 2019, researchers found, a pattern in line with earlier studies showing similar growth in the cardiogenic shock space.
(National-NBC) July 12, 2006 - Though she was at death's door last week, a 19-year-old woman - hooked up to a device called the TandemHeart - has made one of the most dramatic recoveries doctors have ...
HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio ...
Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & ...
October 21, 2010 (Houston, Texas) — A new study shows percutaneous ventricular assist devices (pVADs) may provide a ray of light for a group of patients with an otherwise dark prognosis [1]. The ...
CAMPBELL, Calif., Shifamed, LLC announced today the $15.5M financing of Supira Medical, the newest Shifamed portfolio company. The financing, led by The Capital Partnership (TCP) with participation ...
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic ...
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results